Clinical Study of Butylphthalide Soft Capsule Combined with Vinpocetine Injection in Patients with Acute Cerebral Infarction
This paper analzyes the clinical effect of butylphthalide soft capsule combined with vinpocetine injection on patients with acute cerebral infarction. According to the random number table method, 40 patients were divided into two groups. The control group was treated with butylphthalide soft capsule. The observation group was based on this. Combined with vinpocetine injection, the blood rheology index, NIHSS score and ADL score before and after treatment were compared between the two groups. The clinical effect and complications after treatment. Before treatment, there was no significant difference in blood rheology index, NIHSS score and ADL score between the two groups (P>0.05). There was no significant difference in the incidence of complications between the two groups after treatment (P>0.05); NIHSS score in the observation group The hemorheology indexes of the two groups were lower than those of the control group (P<0.05). The ADL score and the total clinical effective rate of the observation group were higher than those of the control group (P<0.05). Butylphthalide soft capsule combined with vinpocetine injection has a significant effect on patients with acute cerebral infarction. It can effectively improve the patients' ability of self-care, promote the recovery of nerve function, and improve the total effective rate of treatment. It is worthy of application.